Rita Jain
Director/Board Member presso CELLDEX THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Rita I.
Jain is currently working as a Director at AnaptysBio, Inc., an Independent Director at Celldex Therapeutics, Inc., and a Member-Supervisory Board at both AM-Pharma Holding BV and AM-Pharma BV.
Previously, she held positions such as Chief Medical Officer, Executive Director & EVP at ChemoCentryx, Inc., Director at Provention Bio, Inc., Vice President-Pharmaceutical Development at Abbott Laboratories, Vice President-Health & Metabolic Development at AbbVie, Inc., Chief Medical Officer & Senior Vice President at Akebia Therapeutics, Inc., and Chief Medical Officer & Senior Vice President at Immunovant, Inc. She also served as an Assistant Professor at New York University School of Medicine and is a Member of North Shore University Hospital.
Dr. Jain completed her undergraduate degree at Long Island University and obtained her doctorate from Stony Brook University School of Medicine.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ANAPTYSBIO, INC.
-.--% | 03/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Rita Jain
Società | Posizione | Inizio |
---|---|---|
CELLDEX THERAPEUTICS, INC. | Director/Board Member | 16/02/2023 |
ANAPTYSBIO, INC. | Director/Board Member | 06/04/2023 |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Director/Board Member | 01/07/2020 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Director/Board Member | 01/01/2020 |
Precedenti posizioni note di Rita Jain
Società | Posizione | Fine |
---|---|---|
PROVENTION BIO, INC. | Director/Board Member | 27/04/2023 |
CHEMOCENTRYX, INC. | Chief Tech/Sci/R&D Officer | 20/10/2022 |
IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 01/06/2021 |
AKEBIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/06/2019 |
ABBVIE INC. | Corporate Officer/Principal | 01/01/2012 |
Formazione di Rita Jain
Long Island University | Undergraduate Degree |
Stony Brook University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 6 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ANAPTYSBIO, INC. | Health Technology |
ABBVIE INC. | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
CELLDEX THERAPEUTICS, INC. | Health Services |
IMMUNOVANT, INC. | Health Technology |
Aziende private | 5 |
---|---|
ChemoCentryx, Inc.
ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Health Technology |
North Shore University Hospital
North Shore University Hospital Hospital/Nursing ManagementHealth Services North Shore University Hospital Manhasset provided health care services. The company was headquartered in Manhasset, NY. | Health Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
Provention Bio, Inc.
Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
- Borsa valori
- Insiders
- Rita Jain